Research Store

Research Store

Research Store
add to cart Register yourself and then log-in with your user ID and password, before clicking on 'Add to Cart'
Issue Date:Oct 3 2015 12:00AM     Price in Rs. R 6000    Price in USD. $ 100

Dr Lal Pathlabs (DLPL) traces its roots to 1949, when Late Dr. Major S.K. Lal, commenced the business of providing pathology services and maintaining a blood bank.


Now DLPL is India’s second largest diagnostic lab business by absolute revenue. In terms of net profits, it appears to be ahead of all others, including revenue leader SRL. It offers 3,368 diagnostic and related healthcare tests and services, covering just about every possible testing requirement.


It has built a national network consisting of our National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015.


The company is planning to go public, driven by a desire to give exit to PE investors.


DLPL filed a DRHP with SEBI in Sep’15, wherein the promoters and other existing shareholders will collectively sell 1.16 crore shares of the company amounting to 14.1 per cent stake.

  • Company Background
  • Business Highlights
  • Facilities
  • Industry Scenario
  • Future Plans
  • Finacial Performance


  • Board of Directors
  • Financial Summary
  • Profit & Loss Account
  • Balance Sheet
  • Ratios


Dr Lal’s Pathlab Limited